Share-based Payment Arrangement, Expense of Ocean Biomedical, Inc. from 30 Sep 2022 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ocean Biomedical, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2022 to 31 Mar 2025.
  • Ocean Biomedical, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $186,000, unchanged year-over-year.
  • Ocean Biomedical, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2025 was $745,000, unchanged year-over-year.
  • Ocean Biomedical, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $745,000, a 38% decline from 2023.
  • Ocean Biomedical, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1,205,000, a 90% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Ocean Biomedical, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $745,000 $186,000 $0 0% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $745,000 $186,000 -$1,000 -0.54% 01 Oct 2024 31 Dec 2024 10-K 08 Apr 2025 2024 FY
Q3 2024 $746,000 $186,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 13 Jan 2025 2024 Q3
Q2 2024 $746,000 $187,000 +$1,000 +0.54% 01 Apr 2024 30 Jun 2024 10-Q 23 Dec 2024 2024 Q2
Q1 2024 $745,000 $186,000 -$460,000 -71% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $1,205,000 $187,000 01 Oct 2023 31 Dec 2023 10-K 08 Apr 2025 2024 FY
Q3 2023 $186,000 -$2,748,000 -94% 01 Jul 2023 30 Sep 2023 10-Q 13 Jan 2025 2024 Q3
Q2 2023 $186,000 01 Apr 2023 30 Jun 2023 10-Q 23 Dec 2024 2024 Q2
Q1 2023 $646,000 01 Jan 2023 31 Mar 2023 10-Q 23 Dec 2024 2024 Q1
Q3 2022 $2,934,000 01 Jul 2022 30 Sep 2022 10-Q 15 Apr 2024 2023 Q3

Ocean Biomedical, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $745,000 -$460,000 -38% 01 Jan 2024 31 Dec 2024 10-K 08 Apr 2025 2024 FY
2023 $1,205,000 -$11,173,000 -90% 01 Jan 2023 31 Dec 2023 10-K 08 Apr 2025 2024 FY
2022 $12,378,000 01 Jan 2022 31 Dec 2022 10-K 25 Nov 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.